Blockade of adenosine A2ARs decreases both hippocampal tau phosphorylation and neuroinflammatory response in a tauopathy mouse model (79), and also decreases amyloid burden in the brain and improves cognitive performance in an Aβ-injection model (80, 81). This evidence concerns the gene MAPT and amyloidosis.